Autopheresis-C™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors.

Alyx is designed to help optimize your bottom line with reduced labor and error related costs and the ability to increase collection of high value components.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

The Fresenius healthcare group is continuously expanding its range of innovative products. A new laboratory and office building with a technical center called KabiLab D20 is being built at ...

BioSciences announced that it has settled its litigations with Fresenius Kabi USA, LLC (Fresenius), Jiangsu Hengrui ...

The biggest stories of the day delivered to your inbox.

Bernstein analyst Lisa Bedell Clive maintained a Hold rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) today and set a price target of €50.00. The company’s shares closed last ...

View Our Latest Stock Analysis on FMS Fresenius Medical Care Trading Up 1.3 % Shares of FMS opened at $24.58 on Friday. Fresenius Medical Care AG has a 12-month low of $17.93 and a 12-month high ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...